(AVAI - AVAI BIO INC)

company profile

Avai Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Further, it offers Avant! AI, a platform that has shown impressive results related to the technology's usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avai Bio, Inc. in February 2026. Avai Bio, Inc. was incorporated in 2017 and is based in Vilnius, Lithuania.

Avai Bio (AVAI) is trading at 0.1276

Open Price
0.1574
Previous close
0.15
Previous close
0.15
P/E Ratio
0
Sector
Information Technology
Shares outstanding
138252252
Primary exchange
OTC Markets
ISIN
US89487B1008